drugset / Trial / NCT00315718

Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2)

NCT00315718 ↗

Phase 3 Completed 10 enrolled Harras Pharma Curarina GmbH
Non-randomizedSingle-groupOpen-labelTreatment

Summary

In patients with diabetes mellitus type 2 stably adjusted to diet long-term intake of aqueous-ethanolic extract from Hintonia latiflora over more than 12 months leads to a statstically significant amelioration of parameters of glycaemic control (HbA1c, postprandial and fasting glucose) not acchievable with diet alone. As safety parameters, liver function tests and cardiovascular parameters are to be monitored. Adverse events are to be monitored.

Timeline

Start
2002-06
Primary completion
—
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Hintonia latiflora extract Unknown 2 ml —